Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.

Author: SchröderF H

Paper Details 
Original Abstract of the Article :
Three antiandrogens are or will soon be available for clinical use. Only Flutamide has been studied in monotherapy of prostatic cancer patients. The use of Flutamide is associated with significant side effects. However, previously potent patients usually remain potent under Flutamide monotherapy. Th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2149460

データ提供:米国国立医学図書館(NLM)

A New Oasis in the Treatment of Prostate Cancer: Pure Antiandrogens

The search for effective treatments for [prostatic carcinoma] continues, and researchers are exploring new avenues to combat this challenging disease. This research delves into the potential of [pure antiandrogens] as a monotherapy option for treating prostate cancer, aiming to assess their effectiveness and side effect profile. By evaluating the efficacy and safety of these agents, researchers hope to identify a new and potentially more effective treatment strategy.

Pure Antiandrogens Show Promise in the Treatment of Prostate Cancer

This study explores the potential of [pure antiandrogens] as a monotherapy option for treating [prostatic carcinoma]. While further research is needed to confirm their long-term effectiveness, the initial findings suggest that these agents may offer a viable treatment option, potentially providing a better quality of life for patients compared to standard endocrine therapy. This study highlights the importance of ongoing research to identify the most effective and safe treatment strategies for prostate cancer.

Navigating the Sands of Prostate Cancer Treatment: Pure Antiandrogens Offer Potential

This research highlights the potential of [pure antiandrogens] as a new treatment option for [prostatic carcinoma]. By offering a potential alternative to standard endocrine therapy, these agents could provide patients with a more effective and well-tolerated treatment option, ultimately leading to improved outcomes and a better quality of life.

Dr.Camel's Conclusion

This research presents a compelling case for the potential of pure antiandrogens as a monotherapy option for treating prostatic carcinoma. While further research is needed to confirm their long-term effectiveness, the initial findings suggest that these agents may offer a new and potentially more effective treatment strategy. This research highlights the importance of ongoing research to identify the most effective and safe treatment strategies for this challenging disease.

Date :
  1. Date Completed 1991-03-21
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

2149460

DOI: Digital Object Identifier

2149460

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.